Events › B2B Event
B2B Event
3rd edition
A 3rd edition summit by Hanson Wade focusing on novel obesity therapeutics, metabolic disease, and GLP-1 drug development. It unites R&D leaders, biotech innovators, and clinicians to explore next-generation treatments, clinical trial designs, and drug delivery for obesity management.
Filter this event to your ICP.
Hundreds of exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Why people attend
Senior drug developers and scientists attend to find partners for clinical trials, drug discovery technologies, and specialized services to accelerate obesity therapeutic development.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
More B2B Event events
Past & future editions
More events in United States
Frequently asked questions